» Articles » PMID: 35530143

Inhibition of Gasdermin D-dependent Pyroptosis Attenuates the Progression of Silica-induced Pulmonary Inflammation and Fibrosis

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2022 May 9
PMID 35530143
Authors
Affiliations
Soon will be listed here.
Abstract

Silicosis is a leading cause of occupational disease-related morbidity and mortality worldwide, but the molecular basis underlying its development remains unclear. An accumulating body of evidence supports gasdermin D (GSDMD)-mediated pyroptosis as a key component in the development of various pulmonary diseases. However, there is little experimental evidence connecting silicosis and GSDMD-driven pyroptosis. In this work, we investigated the role of GSDMD-mediated pyroptosis in silicosis. Single-cell RNA sequencing of healthy and silicosis human and murine lung tissues indicated that GSDMD-induced pyroptosis in macrophages was relevant to silicosis progression. Through microscopy we then observed morphological alterations of pyroptosis in macrophages treated with silica. Measurement of interleukin-1 release, lactic dehydrogenase activity, and real-time propidium iodide staining further revealed that silica induced pyroptosis of macrophages. Additionally, we verified that both canonical (caspase-1-mediated) and non-canonical (caspase-4/5/11-mediated) signaling pathways mediated silica-induced pyroptosis activation, and . Notably, knockout mice exhibited dramatically alleviated silicosis phenotypes, which highlighted the pivotal role of pyroptosis in this disease. Taken together, our results demonstrated that macrophages underwent GSDMD-dependent pyroptosis in silicosis and inhibition of this process could serve as a viable clinical strategy for mitigating silicosis.

Citing Articles

Regulatory Roles of Noncanonical Inflammasomes in Inflammatory Lung Diseases.

Yi Y Int J Mol Sci. 2025; 26(1.

PMID: 39795884 PMC: 11719999. DOI: 10.3390/ijms26010027.


Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions.

Liu Y, Wang D, Liu X, Yuan H, Liu D, Hu Y Cell Commun Signal. 2024; 22(1):586.

PMID: 39639365 PMC: 11619304. DOI: 10.1186/s12964-024-01966-3.


Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases.

Wu J, Wang H, Gao P, Ouyang S Acta Pharm Sin B. 2024; 14(10):4195-4227.

PMID: 39525577 PMC: 11544194. DOI: 10.1016/j.apsb.2024.06.026.


Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.

Liu Y, Pan R, Ouyang Y, Gu W, Xiao T, Yang H Signal Transduct Target Ther. 2024; 9(1):245.

PMID: 39300122 PMC: 11413206. DOI: 10.1038/s41392-024-01958-2.


Gasdermin D and Gasdermin E Are Dispensable for Silica-Mediated IL-1β Secretion from Mouse Macrophages.

Leung J, Chang M, Moore R, Dagvadorj J, Sutterwala F, Cassel S Immunohorizons. 2024; 8(9):679-687.

PMID: 39264735 PMC: 11447662. DOI: 10.4049/immunohorizons.2400019.


References
1.
Hamilton Jr R, Thakur S, Holian A . Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med. 2008; 44(7):1246-58. PMC: 2680955. DOI: 10.1016/j.freeradbiomed.2007.12.027. View

2.
Sollberger G, Choidas A, Burn G, Habenberger P, Di Lucrezia R, Kordes S . Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol. 2018; 3(26). DOI: 10.1126/sciimmunol.aar6689. View

3.
Peeters P, Eurlings I, Perkins T, Wouters E, Schins R, Borm P . Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs. Part Fibre Toxicol. 2014; 11:58. PMC: 4243278. DOI: 10.1186/s12989-014-0058-0. View

4.
Chen X, He W, Hu L, Li J, Fang Y, Wang X . Pyroptosis is driven by non-selective gasdermin-D pore and its morphology is different from MLKL channel-mediated necroptosis. Cell Res. 2016; 26(9):1007-20. PMC: 5034106. DOI: 10.1038/cr.2016.100. View

5.
Xia S, Zhang Z, Magupalli V, Pablo J, Dong Y, Vora S . Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021; 593(7860):607-611. PMC: 8588876. DOI: 10.1038/s41586-021-03478-3. View